Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E3CB
|
|||
Former ID |
DIB019452
|
|||
Drug Name |
PMID24749861C34
|
|||
Synonyms |
GTPL8129; BDBM50013820
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C14H13N3O4
|
|||
Canonical SMILES |
C1CN(CC2=C1C3=C(C(=C(C=C3)O)C=O)OC2=O)C(=N)N
|
|||
InChI |
1S/C14H13N3O4/c15-14(16)17-4-3-7-8-1-2-11(19)10(6-18)12(8)21-13(20)9(7)5-17/h1-2,6,19H,3-5H2,(H3,15,16)
|
|||
InChIKey |
YPBDMIVAGFLWPR-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Endoplasmic reticulum to nucleus signaling 1 (ERN1) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J Med Chem. 2014 May 22;57(10):4289-301. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.